Plans for assessment and collection of outcomes {18a}
Main secondary outcome: 24-h SBP at 8 weeks. We will use the validated (AAMI criteria) SpaceLabs 90,207 monitor which is generally considered the “gold standard” for ABPM [
25,
26]. ABPM for 24 h will be conducted at baseline/screening, 8 weeks, and 6 and 12 months follow-up. At each of the three 24-h ABPM assessments, the proper BP cuff size will be determined by measuring each participant’s arm circumference at the mid-point between the acromion and olecranon. Next, the monitor will be initialized, and the participant will be fitted with a SpaceLabs 90,207 monitor. Participants are instructed to hold their arm still (by their side or with their forearm resting on a desk/table when seated) when a reading is being taken. Each participant will be instructed by the study coordinator to try to keep their arm still and in the neutral position (which will be demonstrated for the participant prior to leaving the visit) from the time that she or he feels the arm cuff begin to inflate until it is fully deflated. The study staff is trained on ABPM procedures by 1:1 demonstration and practice with Dr. Bress, study co-I. After demonstrating the ability to place the ABPM and instruct participants appropriately, the staff members are approved to conduct this study assessment.
Dietary intake will be collected using the ASA-24, an online automated 24-h dietary recall system [
27]. The main measure of diet quality will the HEI-2018 [
28], a composite measure that uses food groups and nutrients collected in diet recall to compute the US dietary guidelines into a single measure. Changes in the HEI reflect the overall change in the healthfulness of diet. We will also compute macronutrients and key food group/diet behaviors (e.g., fast food, fruit/vegetable intake) from the ASA-24 data for use in exploratory analysis.
Objective 24-h physical activity data including sedentary behavior will be collected using the ActivPAL4 activity monitor [
18,
19]. This miniature electronic logger is validated to classify time spent lying, sitting, standing, and intensity of physical activity. The device is placed in a waterproof cover and taped to the participants’ middle anterior aspect of the upper thigh, thus avoiding the need to change accelerometer placement when changing clothes. A picture will be drawn on the waterproof cover to depict the correct orientation of the device. Data will be processed and analyzed using the ActivPAL software according to standardized procedures and best practices [
29,
30]. In order to be considered valid data, participants must have 5 days with at least 23 h per day. We are using separate devices for sleep and physical activity because hip/thigh vs. wrist placement is important for measurement of physical activity and sleep [
31,
32].
Other measures of cardiometabolic risk will be measured at screening, week 8, and months 6 and 12 including BMI and body fat estimation using a bioimpedance scale (Tanita of America, Arlington Heights, IL), waist and hip circumference, inflammation (IL-6, CRP), lipids, and HbA1c. Training procedures for body measurements include 1:1 training and practice with Dr. Baron and sign off when the staff member can demonstrate following procedures. We will also evaluate the effects on nocturnal and diurnal BP and on non-dipping BP status defined by ABPM levels as mean nighttime to daytime SBP/DBP ratio of > 0.90 [
33].
Participants will complete measures of patient-reported outcomes at session baseline, week 8, and months 3, 6, 9, and 12, including the PROMIS sleep disturbance and sleep-related impairment [
20], sleepiness [
34], and mood [
21]. The PROMIS sleep disturbance and sleep-related impairment demonstrate strong internal consistency and have been validated to a mean of 50 and SD of 10 points [
20]. The Epworth Sleepiness Scale [
35] is a measure commonly used in clinical practice for sleep disorders. The Patient Health Questionnaire, 8-item measure [
21] is highly correlated with clinical diagnoses of depression, with scores > 10 associated with elevated depression.
We will assess intervention acceptability and user engagement to inform our findings and plan for future studies (Fitbit usage, coaching session attendance and duration, and email lesson engagement and use surveys and open-ended questions at the end of the intervention and follow-up periods).
Data collection forms are not posted publicly but will be made available upon request.
Retention for the assessment visits will be handled by the study staff. During informed consent, the staff will discuss with the participants the differences between intervention and assessment as well as the impact of dropout on the validity of study results, while also highlighting voluntary participation. For participants who drop out of the intervention (defined as nonattendance of the coaching or health education calls from that point to the end of the intervention period), we will continue to attempt to obtain outcome assessments. We will respond with empathy and attempt to collect primary outcomes if the full assessment is not feasible. Monetary incentives include payment for each study component and a $40 bonus for the completion of all sleep and ABPM time points.
Data management {19}
This study will use the secure, web-based Research Electronic Data Capture (REDCap) for data input. Case report forms will be designed to flag out-of-range values. When possible, participants will enter data directly into REDCap. For forms that need to be manually entered (e.g., blood test results, sleep apnea screening), data will be double-checked to verify accuracy. Intervention and control sessions will be stored on Box, a HIPAA-compliant file storage platform. Access to the study data will be limited to the investigators and staff with official roles relevant to the study data.
Confidentiality {27}
All investigators and staff will have up-to-date certification on confidentiality and privacy throughout the Collaborative Institutional Training Initiative (CITI) and will have completed additional HIPAA training through The University of Utah. Physical documents will be kept in folders within locked file cabinets in a locked office. Digital documents will be kept on a HIPAA-compliant Box drive or within REDCap. After the trial, data will be kept for 7 years following the last publication of the data. Names and other identifiable information will not be associated with study data. Participants will be assigned a screening ID number and when enrolled into the study, an individual trial ID number.